These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21461919)

  • 1. Preparation and characterization of self-assembled nanoparticles based on folic acid modified carboxymethyl chitosan.
    Tan YL; Liu CG
    J Mater Sci Mater Med; 2011 May; 22(5):1213-20. PubMed ID: 21461919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro.
    Tan YL; Liu CG
    Colloids Surf B Biointerfaces; 2009 Mar; 69(2):178-82. PubMed ID: 19124228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
    Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
    J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.
    Sahu SK; Mallick SK; Santra S; Maiti TK; Ghosh SK; Pramanik P
    J Mater Sci Mater Med; 2010 May; 21(5):1587-97. PubMed ID: 20111985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
    Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
    J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
    Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
    Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
    Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
    Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
    Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of folate modified chitosan-based nanomicelles and its
    Liu L; Huang G; Bai H; Tang G
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):364-374. PubMed ID: 32762172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
    Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R
    Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
    Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
    J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
    Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
    J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
    Lee KD; Choi SH; Kim DH; Lee HY; Choi KC
    Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.
    Song H; Su C; Cui W; Zhu B; Liu L; Chen Z; Zhao L
    Biomed Res Int; 2013; 2013():723158. PubMed ID: 24282819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
    Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
    Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.